Sino Medical Sciences Technology In - Asset Resilience Ratio
Sino Medical Sciences Technology In (688108) has an Asset Resilience Ratio of 0.66% as of March 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 688108 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (None–None)
This chart shows how Sino Medical Sciences Technology In's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see total assets of Sino Medical Sciences Technology In.
Liquid Assets Composition Over Time
This chart breaks down Sino Medical Sciences Technology In's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read how much debt does Sino Medical Sciences Technology In carry for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥8.54 Million | 0.66% |
| Total Liquid Assets | CN¥8.54 Million | 0.66% |
Asset Resilience Insights
- Limited Liquidity: Sino Medical Sciences Technology In maintains only 0.66% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Sino Medical Sciences Technology In Industry Peers by Asset Resilience Ratio
Compare Sino Medical Sciences Technology In's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Eurobio Scientific SA
PA:ALERS |
Medical Devices | 10.52% |
|
Profound Medical Corp
TO:PRN |
Medical Devices | 67.66% |
|
EBR Systems Inc
AU:EBR |
Medical Devices | 54.70% |
|
Epitomee Medical Ltd
TA:EPIT |
Medical Devices | 0.24% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Aligned Genetics Inc
KQ:238120 |
Medical Devices | 2.22% |
Annual Asset Resilience Ratio for Sino Medical Sciences Technology In (None–None)
The table below shows the annual Asset Resilience Ratio data for Sino Medical Sciences Technology In.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| No yearly data available. | ||||
About Sino Medical Sciences Technology In
Sino Medical Sciences Technology Inc., a medical device company, engages in the research, development, production, and distribution of interventional medical devices in China. Its products include coronary drug stents, coronary balloons catheter, intracranial rapid exchange balloons, and intracranial drug-eluting stents, as well as transapical mitral valve replacement system. Sino Medical Science… Read more